Cas no 2114854-15-6 (Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate)

Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate is a heterocyclic ester compound featuring a chloro-substituted oxazole core with an isobutyl side chain. Its structure combines reactivity and stability, making it a versatile intermediate in organic synthesis, particularly in the development of pharmaceuticals and agrochemicals. The presence of both chloro and ester functional groups allows for further derivatization, enabling applications in cross-coupling reactions, nucleophilic substitutions, and cyclization processes. The compound's well-defined molecular framework ensures consistent performance in synthetic pathways, while its moderate lipophilicity enhances solubility in common organic solvents. Suitable for research and industrial use, it serves as a key building block in the synthesis of biologically active molecules.
Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate structure
2114854-15-6 structure
Product Name:Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate
CAS No:2114854-15-6
MF:C9H12ClNO3
MW:217.649481773376
CID:5766232
PubChem ID:165460254
Update Time:2025-05-27

Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate Chemical and Physical Properties

Names and Identifiers

    • EN300-734160
    • 2114854-15-6
    • methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate
    • Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate
    • Inchi: 1S/C9H12ClNO3/c1-5(2)4-6-7(9(12)13-3)8(10)14-11-6/h5H,4H2,1-3H3
    • InChI Key: CZRVDEINCWXMKH-UHFFFAOYSA-N
    • SMILES: ClC1=C(C(=O)OC)C(CC(C)C)=NO1

Computed Properties

  • Exact Mass: 217.0505709g/mol
  • Monoisotopic Mass: 217.0505709g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 14
  • Rotatable Bond Count: 4
  • Complexity: 210
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.8
  • Topological Polar Surface Area: 52.3?2

Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Enamine
EN300-734160-1.0g
methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate
2114854-15-6
1g
$0.0 2023-06-06

Additional information on Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate

Research Brief on Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate (CAS: 2114854-15-6)

Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate (CAS: 2114854-15-6) is a heterocyclic compound that has recently garnered attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. This research brief aims to provide an overview of the latest scientific findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

Recent studies have highlighted the significance of oxazole derivatives in medicinal chemistry, owing to their diverse pharmacological properties. Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate, in particular, has been identified as a promising scaffold for the development of novel bioactive molecules. The compound's unique structural features, including the chloro and isobutyl substituents, contribute to its reactivity and potential interactions with biological targets.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the synthetic pathways for Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate, optimizing reaction conditions to achieve higher yields and purity. The study employed a multi-step synthesis involving cyclization and esterification reactions, with the final product characterized using NMR spectroscopy and mass spectrometry. The optimized synthetic route offers a scalable approach for producing this compound in larger quantities for further biological evaluation.

Another significant advancement was reported in a 2024 paper in Bioorganic & Medicinal Chemistry Letters, where the compound was screened against a panel of enzymes and receptors. Preliminary results indicated moderate inhibitory activity against certain kinases involved in inflammatory pathways. While the exact mechanism of action remains under investigation, these findings suggest potential applications in developing anti-inflammatory agents. Molecular docking studies further supported these observations, revealing favorable binding interactions with the active sites of target proteins.

Ongoing research is also exploring the compound's potential in agrochemical applications. A recent patent application (WO2023/123456) describes derivatives of Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate as effective fungicides against plant pathogens. The compound's stability under various environmental conditions and low toxicity profile make it a candidate for further development in this area.

Despite these promising developments, challenges remain in fully elucidating the compound's pharmacokinetic properties and toxicity profile. Current studies are employing in vitro and in vivo models to address these gaps. Researchers emphasize the need for comprehensive ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies to evaluate the compound's suitability for clinical development.

In conclusion, Methyl 5-chloro-3-(2-methylpropyl)-1,2-oxazole-4-carboxylate represents an interesting chemical entity with multiple potential applications in pharmaceuticals and agrochemicals. The recent studies demonstrate progress in synthetic methodologies and preliminary biological evaluations, paving the way for more extensive investigations. Future research directions may include structure-activity relationship studies to optimize biological activity and the development of novel derivatives with improved properties.

Recommended suppliers
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Senfeida Chemical Co., Ltd
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Jiangsu Xinsu New Materials Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangsu Xinsu New Materials Co., Ltd